The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.
The global Statins market was valued at US$ 14430 million in 2023 and is anticipated to reach US$ 16430 million by 2030, witnessing a CAGR of 1.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Statins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Statins.
Report Scope
The Statins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Statins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Statins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma
Segment by Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Statins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Statins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.
The global Statins market was valued at US$ 14430 million in 2023 and is anticipated to reach US$ 16430 million by 2030, witnessing a CAGR of 1.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Statins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Statins.
Report Scope
The Statins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Statins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Statins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma
Segment by Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Statins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Statins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Statins Market Overview
1.1 Product Overview and Scope of Statins
1.2 Statins Segment by Type
1.2.1 Global Statins Market Value Comparison by Type (2024-2030)
1.2.2 Astrovastatin
1.2.3 Fluvastatin
1.2.4 Lovastatin
1.2.5 Pravastatin
1.2.6 Simvastatin
1.2.7 Others
1.3 Statins Segment by Application
1.3.1 Global Statins Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Statins Market Size Estimates and Forecasts
1.4.1 Global Statins Revenue 2019-2030
1.4.2 Global Statins Sales 2019-2030
1.4.3 Global Statins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Statins Market Competition by Manufacturers
2.1 Global Statins Sales Market Share by Manufacturers (2019-2024)
2.2 Global Statins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Statins Average Price by Manufacturers (2019-2024)
2.4 Global Statins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Statins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Statins, Product Type & Application
2.7 Statins Market Competitive Situation and Trends
2.7.1 Statins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Statins Players Market Share by Revenue
2.7.3 Global Statins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Statins Retrospective Market Scenario by Region
3.1 Global Statins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Statins Global Statins Sales by Region: 2019-2030
3.2.1 Global Statins Sales by Region: 2019-2024
3.2.2 Global Statins Sales by Region: 2025-2030
3.3 Global Statins Global Statins Revenue by Region: 2019-2030
3.3.1 Global Statins Revenue by Region: 2019-2024
3.3.2 Global Statins Revenue by Region: 2025-2030
3.4 North America Statins Market Facts & Figures by Country
3.4.1 North America Statins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Statins Sales by Country (2019-2030)
3.4.3 North America Statins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Statins Market Facts & Figures by Country
3.5.1 Europe Statins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Statins Sales by Country (2019-2030)
3.5.3 Europe Statins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Statins Market Facts & Figures by Country
3.6.1 Asia Pacific Statins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Statins Sales by Country (2019-2030)
3.6.3 Asia Pacific Statins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Statins Market Facts & Figures by Country
3.7.1 Latin America Statins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Statins Sales by Country (2019-2030)
3.7.3 Latin America Statins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Statins Market Facts & Figures by Country
3.8.1 Middle East and Africa Statins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Statins Sales by Country (2019-2030)
3.8.3 Middle East and Africa Statins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Statins Sales by Type (2019-2030)
4.1.1 Global Statins Sales by Type (2019-2024)
4.1.2 Global Statins Sales by Type (2025-2030)
4.1.3 Global Statins Sales Market Share by Type (2019-2030)
4.2 Global Statins Revenue by Type (2019-2030)
4.2.1 Global Statins Revenue by Type (2019-2024)
4.2.2 Global Statins Revenue by Type (2025-2030)
4.2.3 Global Statins Revenue Market Share by Type (2019-2030)
4.3 Global Statins Price by Type (2019-2030)
5 Segment by Application
5.1 Global Statins Sales by Application (2019-2030)
5.1.1 Global Statins Sales by Application (2019-2024)
5.1.2 Global Statins Sales by Application (2025-2030)
5.1.3 Global Statins Sales Market Share by Application (2019-2030)
5.2 Global Statins Revenue by Application (2019-2030)
5.2.1 Global Statins Revenue by Application (2019-2024)
5.2.2 Global Statins Revenue by Application (2025-2030)
5.2.3 Global Statins Revenue Market Share by Application (2019-2030)
5.3 Global Statins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Statins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Statins Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Statins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Statins Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Statins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Statins Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Novartis International
6.4.1 Novartis International Corporation Information
6.4.2 Novartis International Description and Business Overview
6.4.3 Novartis International Statins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis International Statins Product Portfolio
6.4.5 Novartis International Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Statins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Statins Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Statins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biocon Statins Product Portfolio
6.6.5 Biocon Recent Developments/Updates
6.7 Concord Biotech
6.6.1 Concord Biotech Corporation Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Statins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Concord Biotech Statins Product Portfolio
6.7.5 Concord Biotech Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Statins Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aurobindo Pharma Statins Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Statins Industry Chain Analysis
7.2 Statins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Statins Production Mode & Process
7.4 Statins Sales and Marketing
7.4.1 Statins Sales Channels
7.4.2 Statins Distributors
7.5 Statins Customers
8 Statins Market Dynamics
8.1 Statins Industry Trends
8.2 Statins Market Drivers
8.3 Statins Market Challenges
8.4 Statins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Statins Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Statins Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Statins Market Competitive Situation by Manufacturers in 2023
Table 4. Global Statins Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Statins Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Statins Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Statins Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Statins Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Statins, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Statins, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Statins, Product Type & Application
Table 12. Global Key Manufacturers of Statins, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Statins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Statins as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Statins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Statins Sales by Region (2019-2024) & (K Units)
Table 18. Global Statins Sales Market Share by Region (2019-2024)
Table 19. Global Statins Sales by Region (2025-2030) & (K Units)
Table 20. Global Statins Sales Market Share by Region (2025-2030)
Table 21. Global Statins Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Statins Revenue Market Share by Region (2019-2024)
Table 23. Global Statins Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Statins Revenue Market Share by Region (2025-2030)
Table 25. North America Statins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Statins Sales by Country (2019-2024) & (K Units)
Table 27. North America Statins Sales by Country (2025-2030) & (K Units)
Table 28. North America Statins Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Statins Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Statins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Statins Sales by Country (2019-2024) & (K Units)
Table 32. Europe Statins Sales by Country (2025-2030) & (K Units)
Table 33. Europe Statins Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Statins Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Statins Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Statins Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Statins Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Statins Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Statins Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Statins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Statins Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Statins Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Statins Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Statins Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Statins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Statins Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Statins Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Statins Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Statins Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Statins Sales (K Units) by Type (2019-2024)
Table 51. Global Statins Sales (K Units) by Type (2025-2030)
Table 52. Global Statins Sales Market Share by Type (2019-2024)
Table 53. Global Statins Sales Market Share by Type (2025-2030)
Table 54. Global Statins Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Statins Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Statins Revenue Market Share by Type (2019-2024)
Table 57. Global Statins Revenue Market Share by Type (2025-2030)
Table 58. Global Statins Price (USD/Unit) by Type (2019-2024)
Table 59. Global Statins Price (USD/Unit) by Type (2025-2030)
Table 60. Global Statins Sales (K Units) by Application (2019-2024)
Table 61. Global Statins Sales (K Units) by Application (2025-2030)
Table 62. Global Statins Sales Market Share by Application (2019-2024)
Table 63. Global Statins Sales Market Share by Application (2025-2030)
Table 64. Global Statins Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Statins Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Statins Revenue Market Share by Application (2019-2024)
Table 67. Global Statins Revenue Market Share by Application (2025-2030)
Table 68. Global Statins Price (USD/Unit) by Application (2019-2024)
Table 69. Global Statins Price (USD/Unit) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca Statins Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Statins Product
Table 79. Pfizer Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GlaxoSmithKline Statins Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Novartis International Corporation Information
Table 86. Novartis International Description and Business Overview
Table 87. Novartis International Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novartis International Statins Product
Table 89. Novartis International Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Statins Product
Table 94. Merck Recent Developments/Updates
Table 95. Biocon Corporation Information
Table 96. Biocon Description and Business Overview
Table 97. Biocon Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Biocon Statins Product
Table 99. Biocon Recent Developments/Updates
Table 100. Concord Biotech Corporation Information
Table 101. Concord Biotech Description and Business Overview
Table 102. Concord Biotech Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Concord Biotech Statins Product
Table 104. Concord Biotech Recent Developments/Updates
Table 105. Aurobindo Pharma Corporation Information
Table 106. Aurobindo Pharma Description and Business Overview
Table 107. Aurobindo Pharma Statins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Aurobindo Pharma Statins Product
Table 109. Aurobindo Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Statins Distributors List
Table 113. Statins Customers List
Table 114. Statins Market Trends
Table 115. Statins Market Drivers
Table 116. Statins Market Challenges
Table 117. Statins Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Statins
Figure 2. Global Statins Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Statins Market Share by Type in 2023 & 2030
Figure 4. Astrovastatin Product Picture
Figure 5. Fluvastatin Product Picture
Figure 6. Lovastatin Product Picture
Figure 7. Pravastatin Product Picture
Figure 8. Simvastatin Product Picture
Figure 9. Others Product Picture
Figure 10. Global Statins Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Statins Market Share by Application in 2023 & 2030
Figure 12. Hospitals
Figure 13. Clinics
Figure 14. Global Statins Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Statins Market Size (2019-2030) & (US$ Million)
Figure 16. Global Statins Sales (2019-2030) & (K Units)
Figure 17. Global Statins Average Price (USD/Unit) & (2019-2030)
Figure 18. Statins Report Years Considered
Figure 19. Statins Sales Share by Manufacturers in 2023
Figure 20. Global Statins Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Statins Players: Market Share by Revenue in 2023
Figure 22. Statins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Statins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Statins Sales Market Share by Country (2019-2030)
Figure 25. North America Statins Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Statins Sales Market Share by Country (2019-2030)
Figure 29. Europe Statins Revenue Market Share by Country (2019-2030)
Figure 30. Germany Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Statins Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Statins Revenue Market Share by Region (2019-2030)
Figure 37. China Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Statins Sales Market Share by Country (2019-2030)
Figure 48. Latin America Statins Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Statins Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Statins Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Statins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Statins by Type (2019-2030)
Figure 58. Global Revenue Market Share of Statins by Type (2019-2030)
Figure 59. Global Statins Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Statins by Application (2019-2030)
Figure 61. Global Revenue Market Share of Statins by Application (2019-2030)
Figure 62. Global Statins Price (USD/Unit) by Application (2019-2030)
Figure 63. Statins Value Chain
Figure 64. Statins Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
